Novo Nordisk Wins Metsera in $10B Bid

In a major twist, a Delaware judge denies Pfizer's request to halt Metsera's merger with Novo Nordisk, allowing Metsera to accept a higher, ten-billion-dollar offer. This decision marks a significant shift in the ongoing takeover battle, as both pharmaceutical giants compete for a stronger position in the predicted one hundred and fifty billion dollar obesity drug market by the early next decade.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.